Call for abstracts

Abstract submission

The World Diabetes Congress welcomes original abstracts on subjects relevant to the following six streams:

  • Basic and Clinical Science
  • Diabetes in Indigenous Peoples
  • Education and Integrated Care
  • Global Challenges in Health
  • Living with Diabetes
  • Public Health and Epidemiology

Guidelines

Abstract submission opens 2 February 2015
Abstract submission deadline 17 April 2015, 17.00 Greenwich Mean Time (GMT)

Submission mode: Abstract submission is only possible online at www.wdc2015.org. Abstracts submitted by post, fax or email will NOT be accepted. The online abstract submission module will NOT be available after 17 April 2015, 17.00 Greenwich Mean Time (GMT).

IDF congress profile: In order to submit an abstract, a congress profile must be created giving access to the online abstract submission module. The submitter must ensure accurate contact details are entered. One or several abstracts can be submitted by logging into this congress profile.

Submitting author / Presenting author: If the submitting author is not also the presenting author, the submitting author is responsible for informing the presenting author of all communications received regarding the abstract. The presenting author must be registered by 18 September 2015. If the presenting author is not registered by 18 September 2015 their abstract will be REMOVED from the programme.

Number of submissions: There can only be ONE presenting author per abstract. The same abstract CANNOT be submitted multiple times by listing different presenting authors. An unlimited number of abstracts can be submitted and presented by an individual.

Language: All abstracts must be submitted in English. Should English not be your first language, you may wish to have your abstract examined by a native English speaker prior to submission.

Accuracy of content: Submitted abstracts may be edited online up to the abstract submission deadline of 17 April 2015, 17.00 (GMT). Abstracts CANNOT be edited or revised in any way after the deadline. All accepted abstracts will be published as submitted by the authors. The responsibility for the submission of an accurate and precise abstract lies solely with the authors.

Originality of abstracts: Work published elsewhere before 29 November 2015 should NOT be submitted to the World Diabetes Congress. However, previously submitted work can be resubmitted provided there are new methods and/or findings.

Disclosure of interests: Any financial relationships with commercial entities related to the products or processes described in the work must be correctly disclosed.

Regulatory approval: The submitting author confirms that local regulatory approval has been obtained as required by local laws.

Author consent: The submitting author declares all authors have read and approved the submitted work. 

Copyright transfer: Authors must attest that their submitted work does not infringe any copyright legislation. Copyright for the publication of abstracts is automatically transferred to the International Diabetes Federation upon submission and acceptance of the regulations within the online submission module. For rejected abstracts, the copyright reverts back to the authors

Instructions

  • Category & stream: There are various categories that have been defined for the abstract programme within the six streams. Ensure that you select the MOST relevant stream and then place it in the category which BEST describes the content of your abstract. Categories are used for reviewing and indexing purposes.
  • Abstract title: The title is limited to 120 characters excluding spaces and should be brief and relevant. Special characters should NOT be used in your title but spelt out instead (e.g. α should be written as alpha, β as beta). Only use standard abbreviations and generic drug names in the title.
  • Authors: Only 12 authors and/or study groups can be listed. Only one institution can be entered per author.
  • Abstract body
    • Structure the abstract, if applicable, to include aims, methods, results and discussion/conclusion.
    • Font size and style will be automatically configured by the system.
    • Tables will be accepted in the submission field and count towards the character limit. The character deduction for tables is not fixed and will be generated by the character count shown below the submission field. Graphs, figures and photographs are NOT allowed.
    • The length of the abstract is limited to 2100 characters excluding spaces. Only the abstract body and any inserted tables count towards this character limit. The character count displayed beneath the submission field is final and undisputable.
    • Only commonly accepted abbreviations should be used (e.g. OGTT, IGT, ACEI). Treatment groups or drug names should NOT be abbreviated. Less widely recognised abbreviations may be used if introduced on first usage (e.g. ambulatory blood pressure monitoring, ABPM).
    • Only approved and generic (non-proprietary) drug names should be used.
    • Do NOT enter the title, authors, or grant information into the abstract body submission field but include any references in the abstract body.

Selection and notification process

  • Selection: All submitted abstracts undergo a peer-review process by an international panel of reviewers. Accepted abstracts are selected for poster discussion or poster display. The Programme Committee reserves the right to accept or reject any submitted abstract and re-categorise any accepted abstract. The decision of the Programme Committee is final and irrevocable.
  • Notification: Notice of acceptance or rejection of submitted abstracts will be sent to the submitting authors by mid-July 2015. It is the responsibility of the submitting author to inform all other authors of the status of the abstract. A submitting author may also check their congress profile to see the status of the abstract.
  • Author Registration: Presenting authors of accepted abstracts MUST register for the World Diabetes Congress by 18 September 2015, 17.00 Greenwich Mean Time (GMT). If the entire registration fee is not paid by the deadline, the abstract will be automatically withdrawn and will NOT be presented or published. Presenting authors and submitting authors of all abstracts, accepted or rejected, are entitled to the early registration rate until 18 September 2015.
  • Presenting author changes: Changes to the presenting author for an abstract need to be requested using the appropriate form which can be found on the congress website www.wdc2015.org.

Abstract publication

Publications: All accepted abstracts will be published on the World Diabetes Congress website.

Posters

The World Diabetes CoPosters will be displayed every day near the catering area on the exhibition floor of the congress venue. We aim to provide all accepted abstracts with the ideal platform to gain maximum exposure.

Note to presenting authors:

  • All selected posters will be displayed. Authors should refer to specific instructions provided for dates and times when the posters should be put up and taken down as well as poster dimensions.
  • Poster discussion sessions will take place from Tuesday 1 to Thursday 3 December from 13.00 - 14.00.
  • Presenting authors selected for poster display should attend to their posters daily from 13.00 -14.00.

Late-breaking abstract policy

Please note that the World Diabetes Congress 2015 will not be accepting late-breaking abstracts. All abstracts must be submitted during the regular submission period starting on 2 February and ending on 17 April 2015 at 17.00 GMT

Abstract streams

  • Clinical and Basic Science
  • Diabetes in Indigenous Peoples
  • Education and Integrated Care
  • Global Challenges in Health
  • Living with Diabetes
  • Public Health and Epidemiology

Abstract categories

Authors must select the most appropriate of the six abstract streams. They must then select one category from the list below that best describes the content of their abstract. This category will be used for reviewing and indexing purposes.
• Bariatric surgery
• Blood pressure
• Care delivery
• Cognition, psychology and behaviour
• Comorbidities
• Complications
• Complications - cardiovascular disease
• Complications - eye
• Complications - foot
• Complications - kidney
• Complications - nerve
• Complimentary medicine
• Diabetes advocacy
• Diabetes and cancer
• Diabetes and infections
• Diabetes and the brain
• Diabetes associations
• Diabetes education
• Diabetes epidemiology
• Diabetes in childhood and adolescence
• Diabetes in Indigenous groups
• Diabetes in rural areas
• Diabetes in the elderly
• Diabetes management
• Diagnosis and classification
• Discrimination and diabetes
• Environment and lifestyles
• Epigenetics
• Genetics of type 1 diabetes
• Genetics of type 2 diabetes
• Glucagon
• Glucagon physiology and pathophysiology
• Guidelines, clinical care
• Health professional education and development
• Health services research
• Health workforce
• Healthcare financing
• Hypoglycaemia
• In utero environment
• Incretin physiology and pathophysiology
• Incretin therapies
• Inflammation
• Insulin action
• Insulin secretion, beta-cell function
• Insulin therapy and devices
• Islets - beta-cell biology
• Lipids and lipoproteins
• Living with diabetes
• Microbial flora
• Monogenic forms of diabetes
• Nutrition and diet
• Obesity
• Obesity - physiology and pathophysiology of weight regulation
• Obesity - prevention and management
• Oral glucose-lowering therapies
• Patient engagement and self-management
• Physical activity
• Pregnancy and gestational diabetes
• Primary and secondary prevention
• Psychosocial/behavioural interventions
• Quality assurance in diabetes care
• Rights and responsibilities of people with diabetes
• Screening and risk stratification
• Secondary diabetes
• Stem cell therapy
• Telecommunication, internet and social media
• Traditional healing/therapies
• Transplantation - islet and pancreas
• Type 1 diabetes
• Type 2 diabetes
• Type 2 diabetes in children

WDC Grant 

The World Diabetes Congress grant aims to provide 100 people from around the world with the opportunity to attend the congress and present their work.

Grant applicants should:
• Be no more than 40 years of age at the time of the congress
• Submit an abstract to be approved by the Programme Committee
• Write a personal letter of motivation of maximum 250 words, clearly demonstrating the benefits and learning experience to be derived from attending the congress
• Submit a one-page curriculum vitae (CV) Accepted grantees are offered free registration, 4-nights accommodation and an economy return flight to Vancouver, Canada. 

Online grant submission opens on 2 February and expires on 24 April 2015, 17.00 GMT